Concepedia

Jessica Rine

JR

Statistics

Publications

4

Citations

131

H-Index

4

Active since

2010

Affiliations

Novartis (United States)(Current)

City of Hope

Dana-Farber Cancer Institute

Tufts University

Mayo Clinic in Arizona

Jessica Rine is an author at Novartis (United States) specializing in patient engagement, clinical decision support, and clinical trial protocol review.

Publications per year

2010–2020

4

Publications

4

Phase <scp>II</scp> trial of panobinostat, an oral pan‐deacetylase inhibitor in patients with primary myelofibrosis, post–essential thrombocythaemia, and post–polycythaemia vera myelofibrosis

Daniel J. DeAngelo, Ruben A. Mesa, Warren Fiskus et al. · British Journal of Haematology · 2013 · 70 citations

, , +16

A Phase II Trial of Panobinostat, an Orally Available Deacetylase Inhibitor (DACi), in Patients with Primary Myelofibrosis (PMF), Post Essential Thrombocythemia (ET), and Post Polycythemia Vera (PV) Myelofibrosis

Daniel J. DeAngelo, Ayalew Tefferi, Warren Fiskus et al. · Blood · 2010 · 32 citations

, , +6

Assessing Patient Participation Burden Based on Protocol Design Characteristics

Kenneth Getz, Venkat Sethuraman, Jessica Rine et al. · Therapeutic Innovation & Regulatory Science · 2019 · 19 citations

, , +11

Assessing Patient Participation Burden Based on Protocol Design Characteristics

Kenneth Getz, Venkat Sethuraman, Jessica Rine et al. · Therapeutic Innovation & Regulatory Science · 2020 · 10 citations

, , +11

1–4 of 4